Now I have all the information I need. Let me produce the final consolidated review.

## Summary

This paper introduces Constrained Mass Transport (CMT), a variational framework for learning Boltzmann generators that constructs intermediate densities using both a KL trust-region constraint and an entropy decay constraint between successive steps. The constraints yield a geometric-tempered annealing path that adaptively tunes the schedule, mitigating mass teleportation and mode collapse. Empirically, CMT is evaluated on four molecular systems (d=60 to d=219), including a new ELIL tetrapeptide benchmark, and achieves strong results across EUBO, ESS, and Ramachandran TV distance relative to state-of-the-art baselines FAB and TA-BG, with an ablation study confirming that both constraints are necessary.

## Strengths

- **Principled theoretical framework (Proposition 2.3, Theorem 2.4).** The derivation of optimal intermediate densities under combined trust-region and entropy constraints yields a closed-form geometric-tempered path. The connection to annealing paths is cleanly established and well-motivated by known failure modes of geometric annealing (mass teleportation) and reverse-KL training (mode collapse).
- **Strong empirical performance (Table 1).** CMT achieves the best EUBO across all four molecular systems and the best ESS on every system, with large margins on the larger ones (e.g., 29.63% vs. 18.22% on alanine hexapeptide and 26.06% vs. 13.75% on ELIL tetrapeptide, both vs. TA-BG). All comparisons use the same neural spline flow architecture.
- **Ablation demonstrating necessity of both constraints (Figures 2–3).** The paper systematically shows that removing either constraint leads to mode collapse, entropy instability, or degraded ESS between successive densities. This provides compelling evidence that the combination drives performance.
- **Introduction of the ELIL tetrapeptide benchmark (d=219).** This is a meaningful contribution — the largest molecular system studied to date under energy-only variational sampling — and helps differentiate methods at scale.
- **Negligible computational overhead for the Lagrangian dual optimization (Appendix D.4).** The paper reports that solving for the multipliers accounts for ~0.01% of training time on alanine dipeptide, making the adaptive schedule effectively free.

## Weaknesses

### Major
None.

### Minor

- **The "more than 2.5× higher ESS" claim in the abstract and conclusion is overstated relative to the best competing method.** When compared to the strongest baseline (TA-BG), CMT achieves ~1.63× higher ESS on alanine hexapeptide (29.63% vs. 18.22%) and ~1.90× on ELIL tetrapeptide (26.06% vs. 13.75%). The 2.5× figure only arises when comparing against FAB on ELIL (3.6×) and is not representative of the improvement over the best method. Since the abstract does not qualify the baseline, this overstates the typical gain and should be corrected to a more accurate characterization (e.g., "up to 2.5×" or "substantially higher").

- **The claim "Across all systems and metrics, our method outperforms the baselines" (Section 5.2) is technically inaccurate.** On ELIL tetrapeptide, TA-BG achieves better Ram TV (2.54×10⁻² vs. CMT's 3.13×10⁻²). The paper correctly bolds TA-BG for that metric in Table 1, but the text contradicts the table. This should be qualified (e.g., "across nearly all systems and metrics" or "on most metrics").

- **The paper does not verify whether the learned normalizing flows actually satisfy the KL trust-region or entropy decay bounds.** The constraints are derived and solved for the *theoretical* optimal densities, but the practical algorithm fits ĝᵢ₊₁ via importance-weighted forward KL. While the ablation study provides indirect evidence that constraints matter, and the paper notes that λ=η=0 would signal constraint satisfaction, there is no direct measurement of whether ‖D_KL(ĝᵢ₊₁‖ĝᵢ)‖ ≤ ε_tr or H(ĝᵢ) − H(ĝᵢ₊₁) ≤ ε_ent for the learned densities. This leaves a gap between the theoretical justification and empirical mechanism.

### Trivial

- The paper describes CMT as achieving "approximately twice the ESS of competing approaches" on larger systems. While close (1.63× and 1.90×), "approximately twice" is a slight stretch for the 1.63× result on alanine hexapeptide.

## Nice-to-Haves

- **Sensitivity analysis for ε_tr and ε_ent.** The paper uses fixed values across all experiments. A brief study showing how performance varies with these thresholds would strengthen claims of robustness.
- **Wall-clock or gradient-step comparison.** The paper reports only target evaluations for cost comparison. Since methods may differ in per-iteration cost (e.g., CMT's 2D dual solve vs. fixed schedules), reporting wall-clock time or total gradient updates would improve fairness transparency.
- **Analysis of MC estimation error in the dual optimization.** The Lagrangian multipliers are solved using Monte Carlo estimates of Zᵢ₊₁ with samples from the *learned* ĝᵢ. Quantifying how error in these estimates propagates to the path would be informative.

## Removed Points

These points are flagged to be removed; treat them with caution.

- *"The entropy constraint alone does not define a transport from q₀."* — The paper explicitly acknowledges this limitation (Section 2, discussing when H(q₀) ≫ H(p)) and presents the entropy-only variant precisely to illustrate this failure mode. This is not a weakness of the paper.
- *"Without seeing Appendix C.3, the claim about importance weight variance is unverifiable."* — Per guidelines, criticisms that question the existence of appendix content that was stripped by the PDF parser are removed. Appendix content exists in the original submission.
- *"Figure 2 ambiguity about whether ESS is between theoretical or learned densities."* — The paper clearly states "We denote by ĝᵢ the variational approximation of the intermediate density qᵢ," and Figure 2b is described as showing ESS between "successive intermediate densities" in the context of the learned approximations. The ambiguity is resolved on the page.
- *"Missing comparison of number of annealing steps across methods."* — The paper explicitly states it uses a fixed budget of target evaluations for fair benchmarking, which is the standard currency for expensive energy functions. This is an appropriate design choice.
- *Strength Finder claim that "CMT achieves more than 2.5× higher ESS than the next best baseline on alanine hexapeptide (29.63% vs. 18.22%)."* — This is factually wrong (29.63/18.22 ≈ 1.63, not 2.5×). Removed as an error.

## Novel Insights

None beyond the paper's own contributions.

## Suggestions

1. Correct the "more than 2.5× higher ESS" claim in the abstract and conclusion to a more precise formulation (e.g., "up to 2.5× higher ESS" or specify the comparison baseline).
2. Qualify the "across all systems and metrics" statement in Section 5.2 to reflect the ELIL Ram TV result where TA-BG leads.
3. Add a brief analysis of whether the learned densities satisfy the theoretical constraints — even a single figure showing D_KL(ĝᵢ₊₁‖ĝᵢ) vs. ε_tr over training steps would close the evidential gap.
4. Consider adding a sensitivity study for the hyperparameters ε_tr and ε_ent, or at least discuss how they were chosen.

## Score and Decision

MY FINAL SCORE: <score>7.5</score>
MY FINAL DECISION: <decision>Accept</decision>